Gary Archer Ph.D.

Quick facts

Marketed products

• DC · Neurology
  DC is a dopamine agonist that acts on dopamine receptors in the brain.

Phase 1 pipeline

• CMV-DCs with GM-CSF
• RNA-loaded dendritic cell vaccine

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Gary Archer Ph.D. portfolio CI brief
• Gary Archer Ph.D. pipeline updates RSS